Molecular Partners Ag (MOLN) Cash & Equivalents (2020 - 2026)
Molecular Partners Ag (MOLN) recorded Cash & Equivalents of $68.92 million in Q3 2026, down 33.3% from $103.31 million a year earlier and down 18.1% from the prior quarter.
Powered by 
Analysis
Molecular Partners Ag (MOLN) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Molecular Partners Ag reported Cash & Equivalents of $104.4 million, up 47.6% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -7.2% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $70.72 million in FY2024 (-11.4%), $79.81 million in FY2023 (-16.3%), $95.3 million in FY2022 (+21.3%) and $78.6 million in FY2021 (-48.2%).
- The Q3 2026 figure is the lowest quarterly Cash & Equivalents in data going back to Q4 2020.
- On a year-over-year basis, Cash & Equivalents has declined for three consecutive quarters, with growth averaging 8.7% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 47.6% in Q4 2025, against a decline of 48.2% in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $84.11 million (Q2 2026), $80.33 million (Q1 2026) and $104.4 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Molecular Partners Ag | 125.16 Mn | -243.89 Mn | - | 68.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 68.92 Mn |
| Jun 30, 2026 | 84.11 Mn |
| Mar 31, 2026 | 80.33 Mn |
| Dec 31, 2025 | 104.40 Mn |
| Sep 30, 2025 | 103.31 Mn |
| Jun 30, 2025 | 102.69 Mn |
| Mar 31, 2025 | 92.38 Mn |
| Dec 31, 2024 | 70.72 Mn |
| Sep 30, 2024 | 78.23 Mn |
| Jun 30, 2024 | 71.30 Mn |
| Mar 31, 2024 | 75.85 Mn |
| Dec 31, 2023 | 79.81 Mn |
| Sep 30, 2023 | 74.77 Mn |
| Jun 30, 2023 | 70.34 Mn |
| Mar 31, 2023 | 80.94 Mn |
| Dec 31, 2022 | 95.30 Mn |
| Sep 30, 2022 | 71.50 Mn |
| Jun 30, 2022 | 120.46 Mn |
| Mar 31, 2022 | 153.87 Mn |
| Dec 31, 2021 | 78.60 Mn |
API Access
Molecular Partners Ag Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MOLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "MOLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MOLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();